Clinical Trials Browser

Phase 3 × Ondansetron × Tumor-Agnostic × Clear all

NCT03578081 2025-04-06

Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

Phase 3 Completed

690 enrolled 17 charts

Neoplasms

NCT05872893 2023-07-21

Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone

Phase 3 Unknown

Neoplasms